Page 9 - Annual Report 2018
P. 9
1. PROFILE AND PRESENTATION
AN INNOVATIVE, INTEGRATED VISION OF THE FIGHT AGAINST ALZHEIMER’S DISEASE
The CIEN Foundation and the Queen Sofia Foundation share a common
perspective on action in relation to Alzheimer's disease: This disease
requires a comprehensive approach model where research should
be one of the fundamental pillars. The leading exponent of this
integrative model is the Queen Sofia Foundation Alzheimer
Center, where the main backbones of Alzheimer Project
converge.
1. A live-in residence for 156 Alzheimer’s patients.
2. A day-care outpatient center for 40 Alzheimer’s patients.
3. An Alzheimer’s research center: the so-called Alzheimer's
Project Research Unit (UIPA), managed by the CIEN
Foundation.
4. A training center for healthcare staff, relatives and
volunteers.
The management model implemented by the Queen Sofia
Foundation Alzheimer Center has sought to summon the will and
interests of all parties involved: Administration (State, Regional and
Local) and civil society. For this reason, the management of UIPA, devoted
to research, was assigned to the CIEN Foundation, while the Ministry of Family and Social Affairs of the
Region of Madrid is responsible for healthcare and training activities.
FOCUSED ON RESEARCH IN NEURODEGENERATIVE DISEASES
The CIEN Foundation is in charge of the following tasks: implement a model of
translational research that allows to effectively and efficiently transfer the
scientific advances achieved in basic research to clinical practice;
promote the continuous training of professionals involved with the
research in neurodegenerative diseases through seminars, lectures
and doctoral theses; disseminate the calls launched by funding
agencies, both nationally and internationally, promoting
participation; and encourage the implementation of
coordinated research projects in neurodegenerative diseases.
But its function does not end here. From the administrative
point of view, the CIEN Foundation is also responsible for
managing other centers related to research in
neurodegenerative diseases such as the Network Center for
Biomedical Research in Neurodegenerative Diseases (CIBERNED,
for its acronym in Spanish), maintaining collaboration agreements
with the Carlos III Institute of Health for carrying out those
management activities.